RightAnswer Knowledge Solutions provides access to hundreds of data sources. Our premier and proprietary sources include fully-researched documents from well-established experts in the chemical and HazMat fields.
A search in our system for this chemical would return results – all in one place -- in the following categories from the listed data sources.
- Chemical Identification
- Environmental Hazards
- First Aid/Medical Treatment
- Handling/Storage/Shipping/Waste Management
- Personal Protection
- Physical Hazards/Corrective Response Actions
- Physical/Chemical Properties
- Report Abstracts and Studies
- Reproductive Risk
- Toxicology/Health Hazards/Exposure
|Example of Acute Exposure data from MEDITEXT.|
RightAnswer Proprietary Data Sources:
Other Government Links Searched via RegsKnowledge:
State Environmental Regulations
Example Content from MEDITEXT for 93390-81-9:
Please note: this is an extract of information from a larger document. Full document and details are available by subscription.
ACUTE EXPOSURE INFORMATION
- WITH THERAPEUTIC USE
- Dysrhythmias and hypotension have rarely occurred (estimated 1 adverse cardiac event per 200,000 administrations) with therapeutic administration of fosphenytoin. Propylene glycol is not used as a diluent in fosphenytoin (unlike phenytoin), a cardiac effect from its metabolites (largely phenytoin) is the presumed mechanism.
- WITH POISONING/EXPOSURE
- Toxic effects are rare at plasma concentrations less than 20 mcg/mL (80 mcmol/L), but are common in patients with plasma concentrations greater than 30 mcg/mL (120 mcmol/L).
- Common effects include nystagmus, ataxia, dysarthria, mild sedation and CNS depression. Ophthalmoplegia, hyperreflexia, mental status changes, hallucinations, and in severe cases, coma may also occur.
- Hypotension, bradycardia and asystole have resulted from intravenous overdoses of fosphenytoin (NO propylene glycol diluent).
© 2011-2020 RightAnswer.com, Inc. and/or its licensors. All rights reserved. No claim to original U.S. Govt. works.